Targeted Therapies in Oncology
December 2018
Volume: 7
Issue: 12
November 2018
Volume: 7
Issue: 11
October 2018
Volume: 7
Issue: 10
Sept 2018
Volume: 7
Issue: 9
August 2018
Volume: 7
Issue: 8
July 2018
Volume: 7
Issue: 7
June 2018
Volume: 7
Issue: 6
May 2018
Volume: 7
Issue: 5
April 2018
Volume: 7
Issue: 4
March 2018
Volume: 7
Issue: 3
February 2018
Volume: 7
Issue: 2
January 2018
Volume: 7
Issue: 1
December 2017
Volume: 6
Issue: 12
November 2017
Volume: 6
Issue: 11
October 2017
Volume: 6
Issue: 10
September 2017
Volume: 6
Issue: 9
August 2017
Volume: 6
Issue: 8
July 2017
Volume: 6
Issue: 7
June 2017
Volume: 6
Issue: 6
May 2017
Volume: 6
Issue: 5
April 2017
Volume: 6
Issue: 4
March 2017
Volume: 6
Issue: 3
February 2017
Volume: 6
Issue: 2
January 2017
Volume: 6
Issue: 1
November 2016
Volume: 5
Issue: 8
October 2016
Volume: 5
Issue: 7
September 2016
Volume: 5
Issue: 6
July 2016
Volume: 5
Issue: 5
May 2016
Volume: 5
Issue: 4
April 2016
Volume: 5
Issue: 3
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
